Skip to main content
Clinical Trials/NCT03467269
NCT03467269
Completed
Not Applicable

BRUSH Sign: Radiolographic Marker of Cerebral Infarctus Prognosis

Fondation Hôpital Saint-Joseph1 site in 1 country250 target enrollmentFebruary 24, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Infarction
Sponsor
Fondation Hôpital Saint-Joseph
Enrollment
250
Locations
1
Primary Endpoint
autonomy level
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Today the treatment of ischemic stroke in acute phase is based on medicinal or endovascular revascularization. Cerebral MRI sequences help the diagnostic. This procedure uses deoxyhemoglobin as an endogenous tracer. This is also a scorer of cerebral ischemia and the increase lets visualized transcerebral veins in the suffering zone giving a brush aspect. Several studies show the interest of this sign and conclude that deoxyhemoglobin presence is a predictive factor of cerebral ischemia. The aim of the study is to evaluate this brush-sign and correlate it with the prognosis retrospectively.

Registry
clinicaltrials.gov
Start Date
February 24, 2017
End Date
June 30, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age\>18 years old
  • hospitalized for cerebral infarction
  • MCA territory
  • MRI within 24hours
  • Sequence of magnetic susceptibility (SWAN)

Exclusion Criteria

  • Incomplete cerebral infarct
  • MRI not possible

Outcomes

Primary Outcomes

autonomy level

Time Frame: Month 3

measurement of autonomy level by mRS

Study Sites (1)

Loading locations...

Similar Trials